Anonymous ID: df7f44 July 31, 2025, 9:35 p.m. No.23410792   🗄️.is 🔗kun   >>0803 >>0913 >>0928 >>1333

Anon noticed we have surpassed Drip, Drip,,, and are observing a running faucet.

 

If we leave the plug in that sink, it will soon FLOOD.

 

Hallelujah, flood glorious flood, and it's only the beginning.

 

Paul Sperry

@paulsperry_

·

13m

NEW: Declassified docs show Obama's spooks used Washington Post stenographer Ellen Nakashima to plant 3 major Russiagate stories: 1) Crowdstrike/DNC "hack"; 2) ICA Putin-Trump "consensus" and 3) Carter Page "Russian agent" FISAs. Nakashima is a useful idiot and a Pulitzer fraud.

 

>https://x.com/paulsperry_/status/1951116935527092525

Anonymous ID: df7f44 July 31, 2025, 9:55 p.m. No.23410816   🗄️.is 🔗kun   >>0913 >>0928

US and South Korea strike a trade deal with tariffs on Seoul set at 15%

 

-This deal means the duties will be lowered from the 25% that Trump had threatened in his “tariff letter” to Seoul earlier this month.

-South Korea will “give to the United States $350 Billion Dollars for Investments owned and controlled by the United States,” Trump said.

-Seoul’s deal with Washington comes close on the heels of a similar deal between the U.S. and Japan.

 

U.S. President Donald Trump on Wednesday announced that Washington had reached a “Full and Complete” trade deal with Seoul, setting blanket tariffs on the country’s exports to U.S. at 15%.

 

This deal means that duties will be lowered from the 25% that Trump had threatened in his “tariff letter” to Seoul earlier this month. Tariffs on the country’s auto exports set at 25% will also be cut to 15%.

 

Trump also said in his post on social media platform Truth Social that South Korea “will give to the United States $350 Billion Dollars for Investments owned and controlled by the United States, and selected by myself, as President.”

 

There appeared to be a difference in the interpretation between Seoul and Washington on how that amount would be utilized.

 

Announcing in a post on Facebook that his country had “concluded tariff negotiations” with the United States, South Korea’s President Lee Jae-myung said that the $350 billion fund “will play a role in facilitating the active entry of Korean companies into the US market in industries where we have strengths, such as shipbuilding, semiconductors, secondary batteries, biotechnology, and energy,” according to a CNBC translation of his statement in Korean.

 

He said $150 billion of that allocation will be for “shipbuilding cooperation providing strong support for Korean companies entering the US shipbuilding industry,” adding that “It’s important to achieve mutually beneficial outcomes, not just pursue unilateral gains.”

 

In comments to CNBC after the deal was announced, Louise Loo, head of Asia economics at advisory firm Oxford Economics, said that the numbers announced so far “don’t add much more clarity — as with the deals [the] US struck with other Asian peers.”

 

U.S. Commerce Secretary Howard Lutnick said that “90% of the profits” from that $350 billion investment will be “going to the American people.” This is similar to what Trump announced about Japan’s investment in the U.S. as part of a trade deal agreed earlier this month, which has reportedly been challenged by Tokyo.

 

Japan’s government said Friday that profits from a $550 billion investment agreed in the tariff deal with the U.S. would be divided between the two countries based on their degree of contributions, according to a Reuters report.

 

Wendy Cutler, senior vice president of the Asia Society Policy Institute and former deputy U.S. trade representative said in a note that “Once a U.S. trade deal was concluded with Japan, Korean negotiators had little choice but to work hard to conclude their own trade deal so as not to be disadvantaged in the U.S. market.”

 

While Seoul did not manage to get any concessions on steel and semiconductors, she noted that it had successfully resisted U.S. calls to further open its beef and rice markets, which Cutler describes as “two highly sensitive sectors.”

 

''More investments''

Trump on Wednesday also said that as part of the deal, Seoul will purchase $100 billion dollars of LNG or other energy products from the U.S, adding that Seoul had also agreed to invest “a large sum of money for their Investment purposes.”

 

The sum will be disclosed when Lee visits Washington for a bilateral summit within the next two weeks, he added.

 

U.S. goods will not be subjected to any tariffs, Trump said. As of 2024, South Korea’s effective tariff rate for goods imported from the U.S. was about 0.79%.

 

ASPI’s Cutler said that the new deal “negates the value of our bilateral FTA where the US and Korea eliminated almost all of their respective tariffs. As an FTA partner, Korea regrettably seems to have not received any special treatment.” Seoul has had a free trade agreement with the U.S. since 2012.

 

U.S. goods trade with South Korea was a little over $197 billion in 2024, according to U.S. government data, and its deficit with the country stood at $66.0 billion in 2024, 29.2% higher from a year earlier.

 

Lee said in his post that “I hope that through this, industrial cooperation between Korea and US will be strengthened and the alliance between Korea and America will also be strengthened,” while adding that Seoul will keep “diplomacy centered on national interest” as its top principle.

 

South Korea will “not be treated any worse than any other country on semiconductors and pharmaceuticals. Steel, aluminum, and copper are not included and remain unchanged,” Lutnick said. Steel, aluminum and copper exports to the U.S. across countries face 50% tariffs.

 

Oxford’s Loo said South Korea locking in a 15% tariff rate for autos like Japan “could be seen as a win for President Lee [Jae Myung].” She cautioned though that tariffs on electronics and semiconductors could still be escalated.

 

South Korea’s benchmark Kospi

index was up 0.5% after the announcement, while yields on its benchmark 10-year bonds were marginally higher.

 

https://www.cnbc.com/2025/07/31/trump-announces-trade-deal-with-south-korea-setting-tariffs-at-15percent.html

Anonymous ID: df7f44 July 31, 2025, 9:55 p.m. No.23410818   🗄️.is 🔗kun   >>0839 >>0913 >>0928

Donald J. Trump

@realDonaldTrump

I don’t care what India does with Russia. They can take their dead economies down together, for all I care. We have done very little business with India, their Tariffs are too high, among the highest in the World. Likewise, Russia and the USA do almost no business together. Let’s keep it that way, and tell Medvedev, the failed former President of Russia, who thinks he’s still President, to watch his words. He’s entering very dangerous territory!

 

https://truthsocial.com/@realDonaldTrump/posts/114945847973193713

Anonymous ID: df7f44 July 31, 2025, 9:56 p.m. No.23410821   🗄️.is 🔗kun   >>0823 >>0825 >>0829 >>0913 >>0928

Donald J. Trump

@realDonaldTrump

Wow! Canada has just announced that it is backing statehood for Palestine. That will make it very hard for us to make a Trade Deal with them. Oh’ Canada!!!

 

https://truthsocial.com/@realDonaldTrump/posts/114945962278773358

Anonymous ID: df7f44 July 31, 2025, 9:57 p.m. No.23410822   🗄️.is 🔗kun   >>0913 >>0928

Not A Single Conservative Guest Has Appeared On 'The View' In 2025

 

After Donald Trump won the election in November, reports from within ABC News indicated the network aimed to feature more conservative-leaning guests on The View to balance the discussion. However, a new study from the Media Research Center (MRC) reports that the show has actually featured fewer conservative guests since the election.

 

In fact, not a single conservative guest has appeared on "The View" since the start of 2025.

 

"Since coming back after their winter break on January 6, The View invited 102 guests who discussed politics and they all expressed left-leaning viewpoints. During that same period, there were ZERO guests that expressed right-leaning politics," the report states.

 

"Of those 102 left-leaning guests, 19 were Democratic politicians: Sen. Tammy Duckworth (IL), Sen. John Fetterman (PA), Gov. Gretchen Whitmer (MI), Sen. Elizabeth Warren (MA), Rep. Jasmine Crockett (TX) twice, Sen. Amy Klobuchar (MN), Gov. JB Pritzker (IL), Sen. Elissa Slotkin (MI), Sen. Chuck Schumer (NY), Sen. Cory Booker (NJ), Sen. Raphael Warnock (GA), Gov. Wes Moore (MD), former President Joe Biden and former First Lady Jill Biden, former Mayor Rahm Emanuel (IL), former Rep. Anthony Weiner (NY), and Rep. Hakeem Jeffries (NY)."

 

The rest included former Democrat staffers, like Karine Jean-Pierre, and proud liberal elites, such as Eva Longoria, Mark Hamill, and Julieanne Moore.

 

With an impressive 100 percent rate of liberal guests, The View even surpassed late-night television. In June, the MRC reported that 99 percent of late-night guests this year have been either liberal or Democrat.

 

Assuming Stephen Colbert, Jimmy Kimmel, and Jimmy Fallon don't plan on inviting any more conservatives on set for the remainder of the year, "The View" will have to do the same to remain ahead in the race. The challenge is on.

 

To be fair, far-left partisanship hasn’t hurt The View nearly as much as it has late-night television. Since 2018, total ad revenue and viewership for late-night shows on CBS, ABC, and NBC have declined by more than 50 percent. The View remains popular — though really, really dumb.

 

Last week, lead mean girl Sunny Hostin warned that the cancellation of Colbert's program "could lead to the dismantling of our Constitution."

 

No wonder "The View" only invites liberals onto the show. Imagine having to defend that take against even a moderately intelligent conservative.

 

https://www.outkick.com/analysis/not-single-conservative-guest-has-appeared-the-view-2025

Anonymous ID: df7f44 July 31, 2025, 9:59 p.m. No.23410824   🗄️.is 🔗kun   >>0828 >>0833 >>0856 >>0864 >>0913 >>0928

ICE is offering $50,000 signing bonus for new recruits or returning agents

 

WASHINGTON – The Department of Homeland Security (DHS) today launched a new U.S. Immigration and Customs Enforcement (ICE) campaign to recruit brave and heroic Americans to join ICE as federal law enforcement agents and remove the worst of the worst criminal illegal aliens from America’s streets.

 

“Your country is calling you to serve at ICE. In the wake of the Biden administration’s failed immigration policies, your country needs dedicated men and women of ICE to get the worst of the worst criminals out of our country,” said Secretary Kristi Noem. “This is a defining moment in our nation’s history. Your skills, your experience, and your courage have never been more essential. Together, we must defend the homeland.”

 

To support this effort, ICE is offering a robust package of federal law enforcement incentives, including:

-A maximum $50,000 signing bonus

-Student loan repayment and forgiveness options

-25% Law Enforcement Availability Pay (LEAP) for HSI Special Agents

-Administratively Uncontrollable Overtime (AUI) for Enforcement Removal Operations (ERO) Deportation Officers

-Enhanced retirement benefits

 

Backed by significant new funding through the recently signed One Big Beautiful Bill, ICE is rolling out patriotic recruitment posters and benefits to attract the next generation of law enforcement professionals to find, arrest, and remove criminal illegal aliens.

 

Recruitment materials will be distributed across major cities nationwide, college campuses, job fairs, and law enforcement networks beginning this week. ICE encourages Americans with a commitment to public safety, national service, and upholding the rule of law to apply today to jumpstart a fulfilling career in federal law enforcement.

 

For more information or to apply, visit: www.ice.gov/careers

 

https://www.dhs.gov/news/2025/07/29/dhs-launches-defend-homeland-nationwide-recruit-patriots-join-ice-law-enforcement

Anonymous ID: df7f44 July 31, 2025, 10 p.m. No.23410826   🗄️.is 🔗kun   >>0913 >>0928

NEW IMAGES: What Trump’s New White House Ballroom Will Look Like

 

https://thenationalpulse.com/2025/07/31/new-images-what-trumps-new-white-house-ballroom-will-look-like/

Anonymous ID: df7f44 July 31, 2025, 10:01 p.m. No.23410831   🗄️.is 🔗kun

From Durham's Declassified Appendix: Crowdstrike, Origins of Hillary's plan to frame Trump

 

https://threadreaderapp.com/thread/1950922948736418289.html

Anonymous ID: df7f44 July 31, 2025, 10:02 p.m. No.23410832   🗄️.is 🔗kun   >>0836 >>0913 >>0928

Anti NWO 🇺🇸🇮🇹🇺🇸

@Anti__NWO

James Comey testified that the DNC "Russian hack" was determined by Crowdstrike AFTER the Democrats refused to hand over their servers to the FBI.

 

https://x.com/Anti__NWO/status/1950929432669012314

https://www.youtube.com/watch?v=n5nN162faLk

Anonymous ID: df7f44 July 31, 2025, 10:04 p.m. No.23410835   🗄️.is 🔗kun   >>0913 >>0928

From Durham's Declassified Appendix: Crowdstrike, Origins of Hillary's plan to frame Trump, Leonard Benardo (Soros stooge)

 

https://threadreaderapp.com/thread/1950922948736418289.html

Anonymous ID: df7f44 July 31, 2025, 10:06 p.m. No.23410838   🗄️.is 🔗kun   >>0913 >>0928

Brown University reaches agreement with Trump administration, funding to be restored

 

-Brown University has agreed to multiple compliance conditions to restore federal research funds.

-More than $50 million has been frozen since April, causing significant problems for the university.

 

Brown University has agreed to a settlement with the federal government, resolving civil rights compliance investigations and unlocking more than $50 million in frozen medical research funds.

 

In exchange, the Rhode Island Ivy League school agreed to distribute $50 million over the next decade to workforce development groups in Rhode Island and to submit to new oversight on its admissions, campus policies, and programming related to diversity, equity, and inclusion (DEI).

 

A central clause of the agreement states that “no provision… shall be construed as giving the United States authority to dictate Brown’s curriculum or the content of academic speech,” preserving a firewall between federal funding and academic governance.

 

Still, the deal imposes significant compliance conditions, including:

-Affirmative Action Prohibitions: Brown must prove that it no longer uses race or ethnicity in admissions, scholarships, or any programs that promote unlawful diversity goals.

-Campus Policy Adjustments: Brown agreed to align its athletic and housing classifications with federal Title IX definitions of “male” and “female” and to restrict gender-affirming care for minors through university health services.

-Support for Jewish Students: The university pledged to maintain campus resources and conduct a third-party climate survey focused on antisemitism.

-Ongoing Oversight: Brown will submit anonymized demographic data and compliance reports to federal agencies to ensure continued adherence.

 

The agreement includes no fines to the government.

 

In a letter appended to the university’s announcement, Brown President Christina Paxson said the deal preserves the school’s academic freedom while resolving “enormous challenges” posed by the federal funding freeze, which has delayed more than $50 million in payments since April.

 

Federal agencies involved in the probe, including the Department of Education and the Department of Justice, will permanently close open investigations into the university, provided Brown meets all terms.

 

The university did not admit wrongdoing.

 

https://www.campusreform.org/article/brown-university-reaches-agreement-trump-administration-funding-restored/28367

Anonymous ID: df7f44 July 31, 2025, 10:07 p.m. No.23410840   🗄️.is 🔗kun   >>0913 >>0928

Yale University ends gender medication program for minors after federal order

 

-Yale Medicine has ended its pediatric gender medication program following federal pressure to halt 'gender-affirming' treatments for minors.

-In January, President Trump administration issued an executive order banning federal funding for 'gender-affirming' procedures on minors, directing agencies to revoke policies supporting such treatments.

 

Yale Medicine has ended its pediatric gender medication program following federal pressure to halt “gender-affirming” treatments for minors.

 

In a statement, Dana Marnane, director of communications at Yale New Haven Health, said that Yale Medicine’s “pediatric gender program” has offered “high-quality care” to patients concerned about “gender identity,” according to WFSB.

 

“With specialists including pediatric-trained endocrinologists, psychologists, and psychiatrists, the program provided options that included medication treatment, when indicated following a thorough assessment, for its patients experiencing gender dysphoria,” the spokesperson explained. “The program did not include surgical interventions.”

 

Marnane added that, after “carefully monitoring” recent federal executive orders, the school has decided to put an end to its pediatric gender program.

 

“After a thorough assessment of the current environment, we have made the very difficult decision to modify the pediatric gender program to eliminate the medication treatment component of the gender-affirming program for patients under age 19,” Marnane stated.

 

In January, the Trump administration issued an executive order banning federal funding for “gender-affirming” procedures on minors, directing agencies to revoke policies supporting such treatments and to penalize institutions that continue offering them.

 

“Across the country today, medical professionals are maiming and sterilizing a growing number of impressionable children under the radical and false claim that adults can change a child’s sex through a series of irreversible medical interventions,” the executive order states. “This dangerous trend will be a stain on our Nation’s history, and it must end.”

 

Connecticut Children’s also announced that it is going to eliminate its gender care initiative for minors.

 

Connecticut House Minority Leader Vincent Candelora applauded the move, arguing that such procedures should be “delayed” until adulthood.

 

“Federal funding should not support interventions that are better delayed until children reach adulthood and can make decisions with full comprehension of the profound consequences for their bodies and futures,” Candelora stated.

Yale is not the only university to have offered such procedures for minors.

 

UCLA Health has offered “gender-affirming” medical treatments to children and teens identifying as “queer” or “questioning” through its Gender Health Program. Funded in part by tuition and taxpayer dollars, the program provided minors with surgeries like mastectomies and genital reconstruction, along with hormone therapy and fertility services.

 

Like Yale, Penn Medicine recently announced it had stopped performing gender-transition surgeries on minors in compliance with the Trump administration’s executive order.

 

Campus Reform has contacted Yale University for comment. This article will be updated accordingly.

 

https://www.campusreform.org/article/yale-ends-gender-medication-program-minors-federal-order/28358

Anonymous ID: df7f44 July 31, 2025, 10:07 p.m. No.23410842   🗄️.is 🔗kun

Fox News

@FoxNews

WATCH: Left-wing Boomer activists leave a coffin at Republican

@RepBryanSteil's door in a disturbing protest — but the congressman says he is "committed to my work to get this country back on track"

 

https://x.com/FoxNews/status/1950734284685185189

Anonymous ID: df7f44 July 31, 2025, 10:10 p.m. No.23410848   🗄️.is 🔗kun   >>0913 >>0928

Victor Davis Hanson: What the media won’t say about the Cincinnati street brawl

 

Recently, a large group of black youths began pummeling several white adults in downtown Cincinnati.

 

The original altercation apparently broke out between a black and white male in he-said/he-said fashion.

 

But that dispute soon turned into a virtual free-for-all.

 

Numerous male and female black youths sucker-punched a middle-aged woman and a man. Others continued to kick or body slam the victims, who were sprawled on their backs and seemingly unconscious.

 

There were many disturbing aspects to the beat-downs.

 

One, the violence broke out along racial and age fault lines. After the initial one-on-one dispute, groups of black youths swarmed solitary older white bystanders to pound them.

 

Two, the surrounding assembled group of black youths not only failed to intervene to restrain the bullies. They also recorded the beatings for social media and were heard cheering on the one-sided violence.

 

Three, there was neither a police presence nor any timely Good Samaritan interventions.

 

Instead, what ended the attacks was simply the fact that at least two of the targets appeared nearly comatose. So their assailants apparently concluded that their agenda of beating whites into unconsciousness was mostly complete.

 

Four, oddly few of the usual black spokespeople who habitually comment on interracial violence were to be seen.

 

During the fake Jussie Smollett attack, self-appointed leaders from Al Sharpton to Kamala Harris immediately issued warnings about so-called systemic white racism that had reared its ugly head to victimize Smollett.

 

Yet when it was revealed Smollett had concocted the entire charade—and even hired his own assaulters—there were few if any retractions from those once so eager to shout “racist!”

 

Such demagoguery is a well-known pattern dating back to the days of the Tawana Brawley rape hoax, the Duke Lacrosse charade, the Covington kids ruse, the Michael Ford “Hands-up-Don’t Shoot” fabrication, the “pseudo-transformation of George Zimmerman into a ‘white Hispanic,’” or the NASCAR noose fable.

 

Racialists too often concoct white racist attackers and go silent when the evidence proves fabricated—only to be primed to manipulate the next hoax.

 

Five, the media and authorities did their best to either hide or play down the violence.

 

City leaders, the chief of police, and the media variously blamed the mass black-on-white violence on 1) social media, 2) the original one-on-one dispute, 3) alcohol, 4) the lack of civilian intervention to stop the violence, and 5) a festival atmosphere—anything except endemic racial hatred shown toward whites from the crowd of black youths.

 

Six, had a gang of white toughs beat middle-aged African-Americans senseless, recorded it, and cheered on the violence, there would have been immediate national outrage.

 

Nor did anyone wish to raise the taboo topic of inordinate black crime rates, disproportionate to respective demographic realities. In rare interracial violent crimes, the asymmetrical ratio of black-on-white versus white-on-black assaults ranges from three to five times greater.

 

Seven, the quiet of the left-wing media to the reprehensible violence stands in marked contrast with their usual rush-to-judgment racialism in two near-simultaneous incidents.

 

When a shooter of mixed African-American heritage recently entered a New York City corporate headquarters and executed four innocents, CNN falsely raised the speculation that a “white male” was perhaps responsible—despite the photograph of the suspect, who was as clearly male as he was not white.

 

Media and municipal officials jumped to explain the violence as due to the killer’s alleged past traumatic brain injury or because of his access to a semi-automatic weapon—or anything other than his hate-filled plan to murder an NFL executive.

 

Actress and model Sydney Sweeney just cut a jeans commercial in front of a poster that said, “Sydney Sweeney has great genes”—with “genes” crossed out and replaced with “jeans.” The left then exploded, alleging the ad was a supposed Hitlerian reference to white eugenics.

 

Yet the eugenics movement in America was mostly a product of left-wing progressives, from Planned Parenthood founder Margaret Sanger to Democrat president Woodrow Wilson.

 

And the ad’s sponsor, American Eagle, had previously used all sorts of models from all racial backgrounds. All might agree that the ad simply shows both tight, sexy jeans and a naturally attractive wearer—period.

 

The country is descending into a tribal morass of double standards and racial fixations.

 

The diversity/equity/inclusion industry, the Defund-the-Police madness, and the perpetual left-wing hunt for “white racism/white privilege/white rage”—from the prior Pentagon hierarchy to the lunatic fringe of Jasmine Crockett, Joy Reid, and Zohran Mamdani—have all legitimized double standards while lowering the bar of the once unacceptable.

 

When our careerist left-wing elites seek to divide us by race and make it essential, not incidental, to our identities, that tribalist message filters throughout communities.

 

The ensuing signal is that “payback” violence is okay—on the expectation that there are no consequences for interracial violence—as long as the victim is white and the assaulter is not.

 

https://victorhanson.com/the-cincinnati-cop-outs/

Anonymous ID: df7f44 July 31, 2025, 10:11 p.m. No.23410850   🗄️.is 🔗kun   >>0857 >>0913 >>0928

SEC debuts ‘Project Crypto’ to bring U.S. financial markets ‘on chain’

 

-The Securities and Exchange Commission on Thursday debuted “Project Crypto,” an initiative to modernize securities regulations to allow for crypto-based trading.

-The announcement comes amid a surge of interest in tokenization, the process of issuing digital representations on a blockchain of publicly-traded securities or other assets.

-SEC Chair Paul Atkins discussed the importance of preventing crypto companies from being driven offshore by “one-size-fits-all rules.”

 

The Securities and Exchange Commission on Thursday debuted “Project Crypto,” an initiative to modernize securities rules and regulations to allow for crypto-based trading.

 

“To achieve President Trump’s vision of making America the crypto capital of the world, the SEC must holistically consider the potential benefits and risks of moving our markets from an off-chain environment to an on-chain one,” SEC chair Paul Atkins said in remarks to an “American Leadership in the Digital Finance Revolution” conference Thursday afternoon , referring to blockchain technology that enables cryptocurrencies, but has other applications as well.

 

“I have directed the Commission staff to update antiquated agency rules and regulations to unleash the potential of on-chain software systems in our securities markets … Federal securities laws have always assumed the involvement of intermediaries that require regulation, but this does not mean that we should interpose intermediaries for the sake of forcing intermediation where the markets can function without them.”

 

The announcement comes amid a groundswell of investor interest in tokenization, or the process of issuing digital representations on a blockchain network of publicly-traded securities, real world assets or any other form of value. Holders of tokenized assets don’t have outright ownership of the assets themselves. BlackRock CEO Larry Fink has said he sees the “tokenization of every financial asset” as an important step in “the technological revolution in the financial markets.”

 

Crypto trading platforms Robinhood, Gemini and Kraken have all opened tokenized equity offerings to users outside the U.S., and Coinbase has said it’s pushing for SEC for approval to offer a similar service.

 

''Super apps''

Atkins, the SEC chair, highlighted “super apps” (such as one Coinbase introduced two weeks ago) as a priority of his chairmanship, noting the need to allow the apps to thrive with an “efficient licensing structure,” rather than subject to multiple regulatory authorities.

 

So-called super apps like WeChat and Alipay – which bundle several different services and functionalities into a single mobile app – have long been viewed as the holy grail of financial technology by the industry. They’re central to everyday life in China but haven’t been successfully replicated in the West. Meta Platforms and X have made attempts to realize that vision, integrating payments, messaging and social content, among other functions.

 

Atkins also said the Trump administration will work to prevent “innovative” companies from being driven offshore by burdensome regulations, and said the SEC “will encourage our nation’s builders rather than constrain them with red tape and one-size-fits-all rules.”

 

The SEC proposal comes one day after the President’s Working Group on Digital Asset Markets released a long-awaited report with recommendations for the SEC and other federal agencies to build a framework to boost U.S. dominance in digital asset markets. Atkins said he has directed the SEC’s Crypto Task Force, led by Commissioner Hester Peirce, to work with other parts of the SEC to implement the working group recommendations.

 

The Thursday conference was sponsored by the America First Policy Institute, a think tank begun in 2021 to promote President Trump’s policy agenda. The institute was founded by Brooke Rollins, the current Secretary of Agriculture, and Larry Kudlow, Trump’s former director of the National Economic Council.

 

https://www.cnbc.com/2025/07/31/sec-debuts-project-crypto-to-bring-us-financial-markets-on-chain.html

Anonymous ID: df7f44 July 31, 2025, 10:12 p.m. No.23410852   🗄️.is 🔗kun   >>0861

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

 

-President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.

-On Truth Social, Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.

-It comes after Trump in May signed an executive order reviving a controversial policy that aims to slash drug costs by tying the prices of some medicine in the U.S. to the significantly lower ones abroad.

 

President Donald Trump on Thursday said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.

 

On Truth Social on Thursday, Trump posted individual letters he sent 17 drugmakers: AbbVie

, Amgen

, AstraZeneca

, Boehringer Ingelheim, Bristol Myers Squibb

, Eli Lilly

, EMD Serono, Genentech, Gilead

, GSK

, Johnson & Johnson

, Merck

, Novartis

, Novo Nordisk

, Pfizer

, Regeneron

, and Sanofi

.

 

Trump threatened to “deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices” if companies refuse to comply. He asked for each company to commit to his several goals by Sept. 29.

 

The letters come after Trump in May signed an executive order reviving a controversial plan, known as the “most favored nation” policy, that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad. It was Trump’s latest effort to try to rein in U.S. prescription drug prices, which are two to three times higher on average than those in other developed nations – and up to 10 times more than in certain countries, according to the Rand Corp., a public policy think tank.

 

In the letters on Thursday, Trump said drugmakers have proposed potential solutions for high U.S. drug prices. But he said those proposals “promised more of the same: shifting blame and requesting policy changes that would result in billions of dollars in handouts to the industry.”

 

He said moving forward, he will only accept commitments from drugmakers that provide “American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.” Trump said a collaborative effort towards lowering U.S. drug prices would be the “most effective path” for companies, the government and patients.

 

Shares of drugmakers fell following the announcement on Thursday. Shares of Bristol Myers Squibb and Novo Nordisk dropped nearly 5%, GSK and Merck’s stocks fell more than 3% and shares of Sanofi tumbled more than 8%.

 

Here are the steps Trump is asking companies to take:

-He called on drugmakers to provide their full portfolio of existing medicines at the lowest price offered in other developed nations – or what he calls the most-favored-nation price – to every single Medicaid patient.

-Trump also asked companies to contract with the U.S. to guarantee that Medicare, Medicaid and commercial payers receive most-favored-nation prices on all new drugs upon launch and moving forward.

-He called on companies to negotiate harder with what he called “foreign freeloading nations,” adding that U.S. trade policy will try to support that effort. He said increased revenues abroad must be “repatriated to lower drug prices” for American patients and taxpayers through an agreement with the U.S.

-He asked drugmakers to adopt models that sell their medicines directly to consumers or businesses, which effectively eliminates middlemen and aims to ensure that all Americans get the same most-favored nation prices that companies offer to third-party payers.

 

Alex Schriver, senior vice president of PhRMA, the industry’s largest lobbying group, said “importing foreign price controls would undermine American leadership, hurting patients and workers.”

 

The group added that to reduce price differences with other countries, U.S. officials should “rein in health care middlemen driving up costs for Americans and get foreign countries to pay their fair share for innovative medicines.” PhRMA is referring to pharmacy benefit managers, insurers and other payers.

 

In separate statements, spokespeople for Pfizer, Novo Nordisk and Novartis said they are working to find solutions that help Americans access and afford drugs they need.

 

Pfizer said that the company’s discussions with the Trump administration and Congress “have been productive.” Novartis said it is reviewing the letter.

 

The announcement comes just days after AstraZeneca said it has proposed price cuts to certain drugs in the U.S., and that the Trump administration is considering those proposals. AstraZeneca added that it is considering selling some drugs to patients directly, which is a move that companies like Eli Lilly, Novo Nordisk, Pfizer and Bristol Myers Squibb have adopted as patients struggle to afford drugs in the U.S.

 

Drugmakers are also bracing for the president’s planned tariffs on pharmaceuticals imported into the U.S.

 

https://www.cnbc.com/2025/07/31/trump-drug-prices-eli-lilly.html

Anonymous ID: df7f44 July 31, 2025, 10:14 p.m. No.23410860   🗄️.is 🔗kun

Trump rejigs tariff rates ahead of deadline, levies 40% duties on all transshipped goods

 

-Countries that are not listed in the latest order will face an additional duty of 10%.

-The latest tariff rates will start from Aug. 7, a White House official told CNBC-TV18 in an emailed statement.

-“Don’t assume this is the end of the story … more deals and further tariff increases are almost certain to follow,” an analyst said.

 

U.S. President Donald Trump signed an executive order Thursday that modified “reciprocal” tariffs on dozens of countries, with updated duties ranging from 10% to 41%.

 

Trump, in a phone interview with NBC News following the order, said that he would be open to more compelling offers, but it was “too late” for other nations to avoid tariffs set to kick in next week.

 

“It doesn’t mean that somebody doesn’t come along in four weeks and say we can make some kind of a deal,” he said.

 

The latest tariff rates will start from Aug. 7, a White House official told CNBC-TV18 in an emailed statement.

 

“This should not be read as an extension, but to give [the U.S.] Customs and Border Protection ample time to implement these [tariffs],” the official added.

 

Trump said Wednesday in a post on Truth Social that the Aug. 1 deadline for tariffs to restart will remain.

 

“THE AUGUST FIRST DEADLINE IS THE AUGUST FIRST DEADLINE — IT STANDS STRONG, AND WILL NOT BE EXTENDED. A BIG DAY FOR AMERICA!!!” he wrote.

 

Among countries facing the steepest “reciprocal” tariffs, Syria has the highest rate at 41%. Exports from Laos and Myanmar to the U.S. will face a 40% duty. Switzerland and South Africa will be hit with tariffs of 39% and 30%, respectively.

 

For some Asian nations that have not confirmed a trade pact with the U.S., the latest executive order offered some relief with lower duties. The new tariff rates on imports from Thailand will be lowered to 19% from 36%, and those from Malaysia will be reduced to 19% from the 24% rate set earlier.

 

Shipments from Taiwan will face a 20% tariff, lower than the 32% rate set earlier.

 

All goods that are considered to have been transshipped to avoid applicable duties will also be subject to an additional 40% tariff, according to the White House.

 

Countries that are not listed in the latest order will face an additional duty of 10%, the order said. The updated directive modifies tariffs imposed under the earlier executive order issued in April.

 

Trading partners that have reached or are near reaching trade and security agreements with the U.S. will be subject to the modified rates until those agreements are concluded, according to the executive order.

 

The executive order also confirmed new tariff rates agreed upon with trading partners, including the European Union, Japan, South Korea, the Philippines and Indonesia.

 

Wendy Cutler, a former deputy U.S. trade representative, noted that countries running trade deficits with the U.S. were also hit with higher tariffs.

 

“What seems to be absent from the executive order is whether existing or new rules of origin will be issued and/or negotiated. This is of key importance in light of the 40 percent transshipment tariff now applicable beyond Vietnam,” added Cutler, who is also a senior vice president of the Asia Society Policy Institute.

 

Continued uncertainties around upcoming sectoral tariffs and more potential tariff increases will be of particular concern, Cutler said, especially if the Trump administration believes countries are not implementing agreed-upon terms in “good faith.”

 

Stephen Olson, senior visiting fellow at ISEAS-Yusof Ishak Institute and a former U.S. trade negotiator, was of the same view, saying: “Don’t assume this is the end of the story … more deals and further tariff increases are almost certain to follow.”

 

“Countries wishing to trade with the U.S. will now face dramatically higher tariffs that could be further increased at the whim of a president who has shown a disdain for trade rules and agreements, even those he himself has signed,” Olson added.

 

Trump also followed through on his plan to raise tariffs on exports from Canada to 35% from 25%, starting Friday, barring goods that are covered under the U.S.-Mexico-Canada free trade pact he signed during his first term.

 

In early April, Trump announced that the U.S. would impose a 10% blanket tariff rate nearly worldwide, along with individualized duties of up to 50% for dozens of countries.

 

Days later, Trump suspended the higher tariff rates for 90 days, which would have seen them restart on July 9. While claiming that he had no plan to extend that deadline, Trump signed an executive order delaying the date to Aug. 1, days before the new tariff rates were set to kick in.

 

In the lead-up to the Aug. 1 deadline, Trump dispatched letters to more than two dozen world leaders outlining new tariff rates on their exports to the U.S.

 

Most of those new tariff rates were close to the April 2 levels that Trump had initially set using a formula that economists had criticized.

 

On Monday, Trump floated the idea that he would raise the baseline tariff rate to around 15% or 20% on imports from countries that have not negotiated separate trade agreements with the U.S.

 

Asian markets largely fell following the latest announcement, with South Korea’s Kospi

index shedding over 3%, while Japan’s Nikkei 225

dropped 0.66%. Over in Australia, the S&P/ASX 200 benchmark fell 0.76%.

 

Tariffs on exports from China, which face an Aug. 12 deadline following Beijing’s truce with the U.S., are not impacted by this latest directive. Both sides have called the recent U.S.-China trade talks in Stockholm positive, but no agreement has been finalized.

 

“As the dust settles, China has an opportunity to pick up the pieces and seize the mantle, perhaps rhetorically more than in practice, as the leader of rules-based trade,” Olson of the ISEAS-Yusof Ishak Institute said.

 

China will “correctly” perceive the transshipment provision as directed against its interests and may weigh a response in its ongoing trade talks with the U.S., he added.

https://www.cnbc.com/2025/08/01/trump-rejigs-tariff-rates-ahead-of-deadline-levies-40percent-duties-on-all-transshipped-goods.html

Anonymous ID: df7f44 July 31, 2025, 10:16 p.m. No.23410866   🗄️.is 🔗kun   >>0869

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

 

-President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.

-On Truth Social, Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.

-It comes after Trump in May signed an executive order reviving a controversial policy that aims to slash drug costs by tying the prices of some medicine in the U.S. to the significantly lower ones abroad.

 

President Donald Trump on Thursday said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.

 

On Truth Social on Thursday, Trump posted individual letters he sent 17 drugmakers: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, and Sanofi.

 

Trump threatened to “deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices” if companies refuse to comply. He asked for each company to commit to his several goals by Sept. 29.

 

The letters come after Trump in May signed an executive order reviving a controversial plan, known as the “most favored nation” policy, that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad. It was Trump’s latest effort to try to rein in U.S. prescription drug prices, which are two to three times higher on average than those in other developed nations – and up to 10 times more than in certain countries, according to the Rand Corp., a public policy think tank.

 

In the letters on Thursday, Trump said drugmakers have proposed potential solutions for high U.S. drug prices. But he said those proposals “promised more of the same: shifting blame and requesting policy changes that would result in billions of dollars in handouts to the industry.”

 

He said moving forward, he will only accept commitments from drugmakers that provide “American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.” Trump said a collaborative effort towards lowering U.S. drug prices would be the “most effective path” for companies, the government and patients.

 

Shares of drugmakers fell following the announcement on Thursday. Shares of Bristol Myers Squibb and Novo Nordisk dropped nearly 5%, GSK and Merck’s stocks fell more than 3% and shares of Sanofi tumbled more than 8%.

 

Here are the steps Trump is asking companies to take:

 

-He called on drugmakers to provide their full portfolio of existing medicines at the lowest price offered in other developed nations – or what he calls the most-favored-nation price – to every single Medicaid patient.

 

-Trump also asked companies to contract with the U.S. to guarantee that Medicare, Medicaid and commercial payers receive most-favored-nation prices on all new drugs upon launch and moving forward.

 

-He called on companies to negotiate harder with what he called “foreign freeloading nations,” adding that U.S. trade policy will try to support that effort. He said increased revenues abroad must be “repatriated to lower drug prices” for American patients and taxpayers through an agreement with the U.S.

 

-He asked drugmakers to adopt models that sell their medicines directly to consumers or businesses, which effectively eliminates middlemen and aims to ensure that all Americans get the same most-favored nation prices that companies offer to third-party payers.

 

Alex Schriver, senior vice president of PhRMA, the industry’s largest lobbying group, said “importing foreign price controls would undermine American leadership, hurting patients and workers.”

 

The group added that to reduce price differences with other countries, U.S. officials should “rein in health care middlemen driving up costs for Americans and get foreign countries to pay their fair share for innovative medicines.” PhRMA is referring to pharmacy benefit managers, insurers and other payers.

 

In separate statements, spokespeople for Pfizer, Novo Nordisk and Novartis said they are working to find solutions that help Americans access and afford drugs they need.

 

Pfizer said that the company’s discussions with the Trump administration and Congress “have been productive.” Novartis said it is reviewing the letter.

 

The announcement comes just days after AstraZeneca said it has proposed price cuts to certain drugs in the U.S., and that the Trump administration is considering those proposals. AstraZeneca added that it is considering selling some drugs to patients directly, which is a move that companies like Eli Lilly, Novo Nordisk, Pfizer and Bristol Myers Squibb have adopted as patients struggle to afford drugs in the U.S.

 

Drugmakers are also bracing for the president’s planned tariffs on pharmaceuticals imported into the U.S.

 

https://www.cnbc.com/2025/07/31/trump-drug-prices-eli-lilly.html

Anonymous ID: df7f44 July 31, 2025, 10:17 p.m. No.23410870   🗄️.is 🔗kun   >>0872 >>0913 >>0928

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

 

-President Donald Trump said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.

-On Truth Social, Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.

-It comes after Trump in May signed an executive order reviving a controversial policy that aims to slash drug costs by tying the prices of some medicine in the U.S. to the significantly lower ones abroad.

 

President Donald Trump on Thursday said he asked major pharmaceutical companies to take steps to cut U.S. drug prices within the next 60 days.

 

On Truth Social on Thursday, Trump posted individual letters he sent 17 drugmakers: AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron, and Sanofi.

 

Trump threatened to “deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices” if companies refuse to comply. He asked for each company to commit to his several goals by Sept. 29.

 

The letters come after Trump in May signed an executive order reviving a controversial plan, known as the “most favored nation” policy, that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad. It was Trump’s latest effort to try to rein in U.S. prescription drug prices, which are two to three times higher on average than those in other developed nations – and up to 10 times more than in certain countries, according to the Rand Corp., a public policy think tank.

 

In the letters on Thursday, Trump said drugmakers have proposed potential solutions for high U.S. drug prices. But he said those proposals “promised more of the same: shifting blame and requesting policy changes that would result in billions of dollars in handouts to the industry.”

 

He said moving forward, he will only accept commitments from drugmakers that provide “American families immediate relief from the vastly inflated drug prices and an end to the free ride of American innovation by European and other developed nations.” Trump said a collaborative effort towards lowering U.S. drug prices would be the “most effective path” for companies, the government and patients.

 

Shares of drugmakers fell following the announcement on Thursday. Shares of Bristol Myers Squibb and Novo Nordisk dropped nearly 5%, GSK and Merck’s stocks fell more than 3% and shares of Sanofi tumbled more than 8%.

 

Here are the steps Trump is asking companies to take:

-He called on drugmakers to provide their full portfolio of existing medicines at the lowest price offered in other developed nations – or what he calls the most-favored-nation price – to every single Medicaid patient.

-Trump also asked companies to contract with the U.S. to guarantee that Medicare, Medicaid and commercial payers receive most-favored-nation prices on all new drugs upon launch and moving forward.

-He called on companies to negotiate harder with what he called “foreign freeloading nations,” adding that U.S. trade policy will try to support that effort. He said increased revenues abroad must be “repatriated to lower drug prices” for American patients and taxpayers through an agreement with the U.S.

-He asked drugmakers to adopt models that sell their medicines directly to consumers or businesses, which effectively eliminates middlemen and aims to ensure that all Americans get the same most-favored nation prices that companies offer to third-party payers.

 

Alex Schriver, senior vice president of PhRMA, the industry’s largest lobbying group, said “importing foreign price controls would undermine American leadership, hurting patients and workers.”

 

The group added that to reduce price differences with other countries, U.S. officials should “rein in health care middlemen driving up costs for Americans and get foreign countries to pay their fair share for innovative medicines.” PhRMA is referring to pharmacy benefit managers, insurers and other payers.

 

In separate statements, spokespeople for Pfizer, Novo Nordisk and Novartis said they are working to find solutions that help Americans access and afford drugs they need.

 

Pfizer said that the company’s discussions with the Trump administration and Congress “have been productive.” Novartis said it is reviewing the letter.

 

The announcement comes just days after AstraZeneca said it has proposed price cuts to certain drugs in the U.S., and that the Trump administration is considering those proposals. AstraZeneca added that it is considering selling some drugs to patients directly, which is a move that companies like Eli Lilly, Novo Nordisk, Pfizer and Bristol Myers Squibb have adopted as patients struggle to afford drugs in the U.S.

 

Drugmakers are also bracing for the president’s planned tariffs on pharmaceuticals imported into the U.S.

 

https://www.cnbc.com/2025/07/31/trump-drug-prices-eli-lilly.html

Anonymous ID: df7f44 July 31, 2025, 10:20 p.m. No.23410879   🗄️.is 🔗kun   >>0913 >>0928

Amazon’s gloomy earnings forecast overshadows better-than-expected results

 

-Amazon reported second-quarter results after the bell that exceeded expectations.

-The company offered profit guidance for the current quarter that was lighter than Wall Street’s forecast.

-The guidance spooked investors who are eager to see Amazon’s hefty investments in artificial intelligence pay off.

 

Amazon shares slid more than 7% in extended trading on Thursday after the company reported second-quarter results that exceeded expectations, but it gave light operating income guidance for the current period.

 

The stock moved lower during a conference call with investors, as CEO Andy Jassy was asked about growing cloud competition and artificial intelligence spending.

 

Here’s how the company did, compared with estimates from analysts polled by LSEG:

-Earnings per share: $1.68 vs. $1.33 expected

-Revenue: $167.7 billion vs. $162.09 billion expected

 

Wall Street is also looking at other key revenue numbers:

-Amazon Web Services: $30.87 billion vs. $30.8 billion expected, according to StreetAccount

-Advertising: $15.7 billion vs. $14.9 billion expected, according to StreetAccount

 

Jassy tried to reassure investors on the call that AWS has maintained a “pretty significant” leadership position relative to its cloud rivals and he feels optimistic about its AI offerings.

 

Amazon’s second-quarter sales grew 13% year over year to $167.7 billion, an acceleration from a year ago, when revenue expanded 10%.

 

For the current quarter, Amazon said it expects operating income to land between $15.5 billion and $20.5 billion. Analysts were looking for $19.48 billion, according to StreetAccount.

 

The guidance spooked investors who are eager to see Amazon’s hefty investments in artificial intelligence pay off. The company has committed to spend up to $100 billion this year on AI as it races to build out data centers and software.

 

“Our AI progress across the board continues to improve our customer experiences, speed of innovation, operational efficiency, and business growth, and I’m excited for what lies ahead,” Jassy said in the earnings release.

 

Revenue in the third quarter is forecast to be $174 billion to $179.5 billion, representing growth of 10% to 13% year over year. Analysts surveyed by StreetAccount forecast $173.1 billion in revenue.

 

The company’s cloud computing unit saw its revenue climb 18% year over year to $30.87 billion in the second quarter. Analysts polled by StreetAccount had expected $30.8 billion.

 

Amazon Web Services continues to lead the cloud infrastructure market, but it’s facing heightened competition from Microsoft and Google, as the three tech giants ramp up investments to take advantage of the AI boom.

 

While AWS remains in the top spot, revenue growth of about 18% in the quarter trailed Microsoft Azure and Google Cloud, which recorded growth rates in the latest period of 39% and 32%, respectively.

 

Amazon’s advertising business was a particularly bright spot in the results. Ad revenue grew 23% year over year to $15.69 billion in the second quarter, beating StreetAccount estimates of $14.99 billion.

 

The online retail giant’s online advertising unit is dwarfed by Amazon’s retail and cloud units, but it’s become a growing profit center and is also the third-biggest digital ad platform, trailing Meta and Alphabet.

 

Meta said Wednesday that its second-quarter sales, the bulk of which are derived from online advertising, grew 22% year over year. Google

’s advertising sales rose 10% year over year in the second quarter, its parent company Alphabet said last week.

 

For the second quarter in a row, Amazon included “recessionary fears,” along with “tariff and trade policies,” as factors that could affect its guidance. President Donald Trump’s shifting trade policies stand to affect its core retail business the most, though consumer spending has proven to be more resilient than analysts feared.

 

Jassy said on a call with investors that the tariffs haven’t dented demand or driven up prices so far this year.

 

“If costs end up being higher, we will absorb them,” Jassy added.

 

Sales in Amazon’s online stores unit grew 11% year over year to $61.5 billion during the quarter, topping Wall Street’s projected $59 billion, according to StreetAccount.

 

Seller services revenue reached $40.3 billion, which was a 11% year over year increase. Analysts were expecting $38.7 billion in revenue.

 

https://www.cnbc.com/2025/07/31/amazon-amzn-q2-earnings-report-2025.html

Anonymous ID: df7f44 July 31, 2025, 10:23 p.m. No.23410886   🗄️.is 🔗kun   >>0913 >>0928

Apple reports biggest revenue growth since December 2021

 

-Sales of the iPhone grew 13% year over year and overall revenue grew 10% — Apple’s largest quarterly revenue growth since December 2021.

-Apple CEO Tim Cook said Apple would “significantly grow” its AI investments, adding that the company is “open to M&A that accelerates our roadmap.”

-The company also saw success in China during the quarter, with sales rising 4% on an annual basis to $15.37 billion. Cook said a Chinese subsidy for some devices helped Apple in the region.

 

Apple reported third-quarter earnings on Thursday that topped Wall Street expectations for profit and revenue.

 

iPhone sales grew 13% year over year and overall revenue grew 10% — Apple’s largest quarterly revenue growth since December 2021.

 

Apple shares rose in after-hours trading on Thursday and took a leg higher after Apple provided data points about the company’s performance in the September quarter.

 

Here’s how Apple did versus consensus estimates for the quarter ending June 28:

-Earnings per share: $1.57 vs. $1.43 expected

-Revenue: $94.04 billion vs. $89.53 billion expected

-iPhone revenue: $44.58 billion vs. $40.22 billion expected

-Mac revenue: $8.05 billion vs. $7.26 billion expected

-iPad revenue: $6.58 billion vs. $7.24 billion expected

-Other Products revenue: $7.40 billion vs. $7.82 billion expected

-Services revenue: $27.42 billion vs. $26.80 billion expected

-Gross margin: 46.5% vs. 45.9% expected

 

The company provided what it calls color about the company’s performance during the September quarter so far on a call with analysts on Thursday. Apple said it expects mid- to high-single-digit increases in overall revenue, services growth to be similar to this quarter’s 13% year-over-year growth and for gross margin to be between 46% and 47%, even including costs related to tariffs.

 

Apple incurred $800 million in tariff costs in the June quarter, Apple CEO Tim Cook said on the call. That came in lower than the $900 million estimate the company provided in May. For the September quarter, assuming no changes, Apple could incur about $1.1 billion in tariff costs, Cook said.

 

The company reported $1.57 in earnings per share or $24.43 billion of net income during the quarter, versus $1.40 per share or $21.45 billion in the year-ago period.

 

“It was an exceptional quarter by any measure,” Cook told CNBC’s Steve Kovach.

 

Cook said about 1 of the company’s 10 percentage points of revenue growth could be attributed to customers buying more products to get ahead of potential tariffs.

 

The company’s most important business remains the iPhone, which saw 13% growth on an annual basis during the quarter to $44.58 billion in sales.

 

Cook said iPhone revenue was strong because the iPhone 16 is more popular compared to the iPhone 15 devices on sale last year at the same time. Cook said iPhone 16 sales were up “strong double digits” versus its predecessor. Cook specifically highlighted popularity among current iPhone users upgrading to a new one.

 

Apple’s Mac business grew the fastest of any of Apple’s units during the June quarter, growing nearly 15% to $8.05 billion in revenue. Apple released updated MacBook Air laptops, its best-selling Mac, just before the quarter started.

 

The company’s services business, which includes Apple’s warranties, content subscriptions, licensing deals with Google and iCloud continued to grow to $27.42 billion in the period, a 13% increase. Cook highlighted growth in the company’s iCloud subscriptions and said App Store revenue grew “double digits” during the quarter.

 

The two tougher spots in Apple’s report were iPad sales and the company’s other products division, which it sometimes calls its wearables. It consists of Apple Watch, AirPods and other accessories. Revenue for iPad was down 8% to $6.58 billion, despite the company launching a low-cost iPad in March. Apple’s wearables unit declined 8.64% to $7.4 billion during the quarter.

 

Apple also saw success in China during the quarter, with sales rising 4% on an annual basis to $15.37 billion. Apple reports its sales from China, Hong Kong and Taiwan in the same unit. It’s a reversal from the past two quarters, where Apple’s China sales declined 2% in Apple’s second fiscal quarter and 11% in the first quarter.

 

Cook said a Chinese subsidy for some devices helped Apple in the region.

 

“The subsidy does apply to some of our products, and it clearly helps,” Cook said.

 

''‘Significantly growing’ AI investments''

In June, Apple held its annual Worldwide Developers Conference, or WWDC, in which it unveiled new software for iPhones, Macs and other devices, but the company’s artificial intelligence announcements at the event underwhelmed investors.

 

Cook said Apple views AI as “one of the most profound technologies of our lifetime.”

 

“We are significantly growing our investments,” Cook said about AI. “We’re embedding it across our devices, across our platforms and across the company.”

 

Cook said Apple had acquired “around” seven companies so far this year although none had been “huge in terms of dollar amount.”

 

“We’re open to M&A that accelerates our roadmap,” Cook said. Apple had about $133 billion in cash on hand at the end of the June quarter.

 

Asked about the potential for AI devices such as those being developed by OpenAI to threaten sales of the iPhone, Cook said he believed they were likely to be complements to the iPhone, not replacements.

 

“It’s difficult to see a world where iPhone is not living in it,” Cook told analysts on the earnings call.

 

https://www.cnbc.com/2025/07/31/apple-aapl-q3-earnings-report-2025.html

Anonymous ID: df7f44 July 31, 2025, 10:24 p.m. No.23410890   🗄️.is 🔗kun   >>0892 >>0913 >>0928

Elex Michaelson

@Elex_Michaelson

🚨 #BREAKING

@KamalaHarris is NOT running for California Governor 🚨

 

Here’s her statement:

 

“Over the past six months, I have spent time reflecting on this moment in our nation’s history, and the best way for me to continue fighting for the American people and advancing the values and ideals I hold dear.

 

I am a devout public servant, and from the earliest days of my career, I have believed that the best way I could make a difference in people’s lives and fight for a better future was to improve the system from within. And it has been a profound honor to do that work and serve the people of California and our nation—as a prosecutor, Attorney General, United States Senator, and Vice President.

 

In recent months, I have given serious thought to asking the people of California for the privilege to serve as their Governor. I love this state, its people, and its promise. It is my home. But after deep reflection, I’ve decided that I will not run for Governor in this election.

 

I have extraordinary admiration and respect for those who dedicate their lives to public service—service to their communities and to our nation. At the same time, we must recognize that our politics, our government, and our institutions have too often failed the American people, culminating in this moment of crisis. As we look ahead, we must be willing to pursue change through new methods and fresh thinking—committed to our same values and principles, but not bound by the same playbook.

 

For now, my leadership—and public service—will not be in elected office. I look forward to getting back out and listening to the American people, helping elect Democrats across the nation who will fight fearlessly, and sharing more details in the months ahead about my own plans.

 

In the United States of America, power must lie with the people. And We, the People must use our power to fight for freedom, opportunity, fairness, and the dignity of all. I will remain in that fight.”

 

https://x.com/Elex_Michaelson/status/1950632716611035352

Anonymous ID: df7f44 July 31, 2025, 10:26 p.m. No.23410893   🗄️.is 🔗kun   >>0897 >>0913 >>0928

Trump announces historic new US tariffs across the globe

 

Angola: 32% to 15%

Bangladesh: 37% to 20%

Bosnia and Herzegovina: 35% to 30%

Botswana: 37% to 15%

Brunei: 24% to 25%

Cambodia: 49% to 19%

Cameroon: 11% to 15%

Chad: 13% to 15%

Côte d`Ivoire: 21% to 15%

Democratic Republic of the Congo: 11% to 15%

Equatorial Guinea: 13% to 15%

European Union: 20% to 15% (for most goods)

Falkland Islands: 41% to 10%

Fiji: 32% to 15%

Guyana: 38% to 15%

India: 26% to 25%

Indonesia: 32% to 19%

Iraq: 39% to 35%

Israel: 17% to 15%

Japan: 24% to 15%

Jordan: 20% to 15%

Kazakhstan: 27% to 25%

Laos: 48% to 40%

Lesotho: 50% to 15%

Libya: 31% to 30%

Leichtenstein: 37% to 15%

Madagascar: 47% to 15%

Malawi: 17% to 15%

Malaysia: 24% to 19%

Mauritius: 40% to 15%

Moldova: 31% to 25%

Mozambique: 16% to 15%

Myanmar: 44% to 40%

Namibia: 21% to 15%

Nauru: 30% to 15%

Nigeria: 14% to 15%

North Macedonia: 33% to 15%

Pakistan: 29% to 19%

Philippines: 17% to 19%

Serbia: 37% to 35%

South Korea: 30% to 15%

Sri Lanka: 44% to 20%

Switzerland: 31% to 39%

Taiwan: 32% to 20%

Thailand: 36% to 19%

Tunisia: 28% to 25%

Vanuatu: 22% to 15%

Vietnam: 46% to 20%

Zambia: 17% to 15%

Zimbabwe: 18% to 15%

 

https://www.cnn.com/business/live-news/trade-deadline-tariffs-trump-deals

Anonymous ID: df7f44 July 31, 2025, 10:27 p.m. No.23410896   🗄️.is 🔗kun   >>0913 >>0928

AI Researchers Are Negotiating $250 Million Pay Packages Just Like NBA. Stars

 

A.I. technologists are approaching the job market as if they were Steph Curry or LeBron James, seeking advice from their entourages and playing hardball with the highest bidders.

 

Mr. Zuckerberg wanted Mr. Deitke, a 24-year-old artificial intelligence researcher who had recently helped found a start-up, to join Meta’s research effort dedicated to “superintelligence,” a technology that could hypothetically exceed the human brain. The company promised him around $125 million in stock and cash over four years if he came aboard.

 

The offer was not enough to lure Mr. Deitke, who wanted to stick with his start-up, two people with knowledge of the talks said. He turned Mr. Zuckerberg down.

 

So Mr. Zuckerberg personally met with Mr. Deitke. Then Meta returned with a revised offer of around $250 million over four years, with potentially up to $100 million of that to be paid in the first year, the people said. The compensation jump was so startling that Mr. Deitke asked his peers what to do. After many discussions, some of them urged him to take the deal — which he did.

 

Silicon Valley’s A.I. talent wars have become so frenzied — and so outlandish — that they increasingly resemble the stratospheric market for N.B.A. stars.

 

Young A.I. researchers are being recruited as if they were Steph Curry or LeBron James, with nine-figure compensation packages structured to be paid out over several years. To navigate the froth, many of the 20-somethings have turned to unofficial agents and entourages to strategize. And they are playing hardball with the companies to get top dollar, much as basketball players shop for the best deals from teams.

 

The difference is that unlike N.B.A. teams, deep-pocketed A.I. companies like Meta, OpenAI and Google have no salary caps. (Mr. Curry’s most recent four-year contract with the Golden State Warriors was $35 million less than Mr. Deitke’s deal with Meta.) That has made the battles for A.I. talent even wilder.

 

Over the past few weeks, recruiting A.I. free agents has become a spectacle on social media, much like the period before a trade deadline in sports. As Meta, Microsoft, Google and OpenAI have poached employees from one another, job announcements have been posted online with graphics resembling major sports trades, made by the online streaming outlet TBPN, which hosts an ESPN-like show about the tech and business world.

 

Jordi Hays, a co-host of TBPN, said that as tech and A.I. had gone mainstream, more people were following the recruitment fray “the way our friends from college obsess over sports — the personalities, the players, the leagues.”

 

On Wednesday, Mr. Zuckerberg said Meta planned to continue throwing money at A.I. talent “because we have conviction that superintelligence is going to improve every aspect of what we do.” Superintelligent A.I. would not just improve the company’s business, he said, but would also become a personal tool that “has the potential to begin an exciting new era of individual empowerment.”

 

A Meta spokeswoman declined to comment. Mr. Deitke did not respond to a request for comment.

 

The job market for A.I. researchers has long had parallels to professional sports. In 2012, after three academics at the University at Toronto published a research paper describing a seminal A.I. system that could recognize objects like flowers and cars, they auctioned themselves off to the highest corporate bidder — Google — for $44 million.

 

That kicked off a race for talent across the tech industry. By 2014, Peter Lee, Microsoft’s head of research, was likening the market to that for up-and-coming pro football players, many of whom were making about $1 million a year.

 

Editors’ Picks

 

David Geffen’s Divorce Gives New Meaning to an Old Term

 

How to Do a Perfect Plank

 

21 Easy Summer Potluck Recipes You Can Throw Together in 30 Minutes or Less

“Last year, the cost of a top, world-class deep learning expert was about the same as a top N.F.L. quarterback prospect,” Mr. Lee told Bloomberg BusinessWeek at the time, referring to a type of A.I. specialist. “The cost of that talent is pretty remarkable.”

 

The leverage that A.I. researchers have in negotiating job terms has only increased since OpenAI released the ChatGPT chatbot in 2022, setting off a race to lead the technology. They have been aided by scarcity: Only a small pool of people have the technical know-how and experience to work on advanced artificial intelligence systems.

 

That’s because A.I. is built differently from traditional software. These systems learn by analyzing enormous amounts of digital data. Few researchers have experience with the most advanced systems, which require giant pools of computing power available to only a handful of companies.

 

The result has been a fresh talent war, with compensation soaring into the hundreds of millions of dollars a year, from millions of dollars a year.

 

In April, Mr. Zuckerberg — whose company was struggling to advance its A.I. research — dived in by sending personal messages to potential recruits, offering them larger and larger sums.

 

His approach was similar to that of sports franchise owners, two Meta employees said. Even if the offers seemed absurd, if the new hires could help increase revenue by even half a percent — especially for a company that is closing in on a $2 trillion market capitalization — it would be worth it, the people said.

 

“If I’m Zuck and I’m spending $80 billion in one year on capital expenditures alone, is it worth kicking in another $5 billion or more to acquire a truly world-class team to bring the company to the next level?” Mr. Hays said. “The answer is obviously yes.”

Meta’s initial offers to engineers varied but hovered in the mid-tens of millions of dollars, three people familiar with the process said.

 

The company also offered recruits something that was arguably more attractive than money: computing power. Some potential hires were told they would be allotted 30,000 graphical processing units, or GPUs, for their A.I. research, one of the people said. GPUs, which are powerful chips ideal for running the calculations that fuel A.I., are highly coveted.

 

Mr. Zuckerberg has hired with the help of the List, a document with the names of the top minds in A.I., two people familiar with the effort said. Many on the List have three main qualifications: a Ph.D. in an A.I.-related field, experience at a top lab and contributions to A.I. research breakthroughs, one of the people said.

 

The Wall Street Journal previously reported some details of the List.

 

Some researchers on the List have created chat groups on Slack and Discord to discuss offers, two people in the groups said. When someone lands an offer, they can drop the details in the group chats and ask peers to weigh in. (A.I. is a tightknit field where people often know one another.) They trade information about which companies to approach for another offer so they can build up their price, the people said.

 

Working with friends can be just as important as the money. After a researcher joins a new lab, the first thing that person often does is try to recruit friends, two people familiar with the process said.

 

The talent wars have started causing pain. OpenAI has changed its compensation structure to account for the shift in the market, employees at the company said, and is asking those approached by competitors to consult executives before immediately accepting offers.

 

“Are we countering? Yes,” Mark Chen, OpenAI’s chief research officer, said at a company meeting this month, according to a recording reviewed by The New York Times. But he added that OpenAI had not matched Meta’s offers because “I personally think that in order to work here, you have to believe in the upside of OpenAI.”

 

OpenAI declined to comment. (The Times has sued OpenAI and Microsoft, claiming copyright infringement in relation to news content related to A.I. systems. The two companies have denied the claims.)

 

Not all of Meta’s overtures have succeeded. The company has been rebuffed by some researchers, two people said, partly because Mr. Zuckerberg’s vision for artificial intelligence was unclear compared with those at other companies.

 

Still, the frenzy has allowed even little-known researchers like Mr. Deitke to chart their own destinies.

 

Mr. Deitke, who recently dropped out of a computer science Ph.D. program at the University of Washington, had moonlighted at a Seattle A.I. lab, the Allen Institute for Artificial Intelligence. There, he led the development of a project called Molmo, an A.I. chatbot that juggles images, sounds and text — the kind of system that Meta is trying to build.

 

In November, Mr. Deitke and several Allen Institute colleagues founded Vercept, a start-up that is trying to build A.I. agents, which can use other software on the internet to autonomously perform tasks. With about 10 employees, Vercept has raised $16.5 million from investors such as the former Google chief executive Eric Schmidt.

 

Then came Mr. Deitke’s back-and-forth with Mr. Zuckerberg. After Mr. Deitke accepted Meta’s roughly $250 million four-year offer, Vercept’s chief executive posted on social media, “We look forward to joining Matt on his private island next year.”

 

https://www.nytimes.com/2025/07/31/technology/ai-researchers-nba-stars.html?unlocked_article_code=1.ak8.NFwG.8fiTFz0F3t1D&smid=url-share

Anonymous ID: df7f44 July 31, 2025, 10:29 p.m. No.23410898   🗄️.is 🔗kun   >>0913 >>0928

Josh Hawley and Trump make up over PELOSI Act

 

Sen. Josh Hawley is blaming other senators for misleading Donald Trump on his moves to ban congressional stock trading after the president derided the senior Missouri Republican on Truth Social Wednesday evening.

 

Hawley told reporters Thursday morning he has since spoken with Trump and cleared up the confusion.

 

“Senators — I don’t know who — had called and told him yesterday afternoon that the bill had changed at the last minute and would force him to sell all of his assets, sell Mar-a-Lago, sell his properties,” Hawley said the president told him. “That’s just false.”

 

Hawley said he explained that his proposal, which would put a stock trading ban into effect immediately for executive and legislative branch officials, would explicitly exempt the president from having to divest from holdings for the remainder of his term. This fact, according to the senator, changed Trump’s mind about the bill.

 

“He said at the end, ‘Oh ok, great. This is good,’” Hawley said of Trump.

 

https://www.politico.com/live-updates/2025/07/31/congress/hawley-and-trump-make-up-00486881